AzTrials
AzTrials

Advance Care PlanningJUMPNCT06538493

Jumpstarting Advance Care Planning With ANAI People

A study testing JUMPSTART-ANAI in people with Advance Care Planning, run by Southcentral Foundation at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The older Alaska Native/American Indian (ANAI) population is increasing at twice the rate of the general population with a higher burden of serious illness. Older ANAI adults with serious illness are half as likely to have advance directives (AD), indicating a need for improved access to and utilization of advance… Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Advance Care Planning
What is being tested?
JUMPSTART-ANAI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteUnited States
Study dates
1 Apr 2025to 30 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 40 or older with a qualifying serious illness condition (e.g., COPD) OR Age 65 or older (regardless of diagnosis) AND Alaska Native and/or American Indian AND Empaneled to a primary care provider AND 2 or more to primary care in last 12 months AND No advance directives documented in electronic health record

Who cannot join

  • Unable to provide informed consent AND/OR Not able to complete 30-minute study visit by phone, video call, or in person

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Shannon Medlock, MS contact

(907)729-6322

smedlock@scf.cc

John Trainor, PhD, MPH contact

jtrainor@scf.cc

United States1 site, 1 recruiting
  • Southcentral Foundation

    Anchorage, Alaska, 99508

    Richard B Woodbury, MPH, rwoodbury@scf.cc

    Recruiting

Other trials in United States

About this study

Official title: Jumpstarting Advance Care Planning With ANAI People in Primary Care

The older Alaska Native/American Indian (ANAI) population is increasing at twice the rate of the general population with a higher burden of serious illness. Older ANAI adults with serious illness are half as likely to have advance directives (AD), indicating a need for improved access to and utilization of advance care planning (ACP) to ensure that medical care aligns with the values, goals, and preferences of ANAI patients and their families throughout the illness trajectory. The major goals of this cluster randomized trial (CRT) are to (1) evaluate the comparative effectiveness of usual care and JUMPSTART- ANAI, a culturally tailored ACP communication intervention, for prompting patient-driven ACP conversations between ANAI adults and primary care providers and to (1) identify key factors to successfully implement the intervention in health systems serving ANAI adults with serious illness.

Read the detailed description

Despite a disproportionate burden of serious illness, Alaska Native and American Indian (ANAI) people are far less likely than their peers in the general US population to use palliative care, including advance care planning (ACP), which aims to align medical care with patients' values, goals, and preferences. ACP has been demonstrated to result in decreased depression, anxiety, and grief for patients and their families, increased symptom management, and fewer non-beneficial and unwanted end-of-life treatments. ACP is typically documented in advance directives (ADs) that specify patient preferences for life-sustaining treatments and who can make medical decisions on their behalf. Yet, ANAI people ages 55 and older are half as likely to have ADs as their White peers. A previous study culturally tailored and piloted an ACP communication intervention-JUMPSTART-ANAI-among 68 ANAI adults with serious illness in a Tribal health system in Alaska. This project builds on the previous study with a type 1 hybrid effectiveness-implementation trial of JUMPSTART-ANAI. The goal of this study is tailor an implementation plan for JUMPSTART-ANAI, evaluate the comparative effectiveness of the intervention and usual care for promoting patient-driven ACP communication, as measured by ADs documented in the electronic health record and identify key factors for successfully implementing JUMPSTART-ANAI in primary care systems serving ANAI adults with serious illness. Increasing access to culturally appropriate, evidence-based ACP is a high priority for Alaska Native health leaders and communities. By evaluating the effectiveness of a culturally tailored ACP intervention and tailoring implementation of the intervention for use in routine primary care, this study will generate critical information for implementing and improving palliative care services among a rapidly growing population of ANAI adults with serious illness.

Being tested
JUMPSTART-ANAI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • JUMPSTART-ANAIBehavioural

    Patient questionnaire about experiences, preferences, and concerns regarding ACP followed by feedback form with "tips" for initiating ACP conversation with provider at next clinical visit.

Study groups in NCT06538493
Study groupRoleWhat they receive
Jumpstart 1ExperimentalQuestionnaire on advance care planning experiences, preferences, and concerns
Receives: Behavioral: JUMPSTART-ANAI
Jumpstart 2Active comparatorQuestionnaire on advance care planning experiences, preferences, and concerns plus feedback form (patient and provider)
Receives: Behavioral: JUMPSTART-ANAI
Usual careNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with an advance directive in the electronic health record

    New advance directive scanned into EHR

    Measured: Baseline, 3 months, 6 months, 12 months

Secondary outcomes (2)
  1. Quality of communication

    Patient-rated quality of patient-provider communication

    Measured: Baseline, 3 months

  2. Psychological distress

    Symptoms of anxiety and depression

    Measured: Baseline, 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2024
  2. Study start1 Apr 2025
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06538493
Sponsor's protocol ID
5R01NR020491
Other IDs
5R01NR020491
Acronym
JUMP
Status last verified
Jun 2026
First submitted
1 Aug 2024
Last updated
9 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared. All data owned by Tribal authority.

Publications

  • Lillie KM, Dirks LG, Curtis JR, Candrian C, Kutner JS, Shaw JL. Culturally Adapting an Advance Care Planning Communication Intervention With American Indian and Alaska Native People in Primary Care. J Transcult Nurs. 2020 Mar;31(2):178-187. doi: 10.1177/1043659619859055. Epub 2019 Jul 1.

    PubMed 31258037
  • Shaw J, Medlock S, Singh RS, Piromalli C, Trainor JK, Johnson R, Rollolazo S, Fieldhouse C, Mortenson R, Landes SJ. Evaluating a tailored communication tool to increase advance care planning among Alaska Native and American Indian people in primary care: A type 1 hybrid effectiveness-implementation cluster randomized trial protocol. Contemp Clin Trials. 2026 Jun;165:108305. doi: 10.1016/j.cct.2026.108305. Epub 2026 Apr 12.

    PubMed 41974413
  • Singh RS, Landes SJ, Medlock S, Piromalli C, Mortenson R, Shaw J. Collaborative Implementation Planning to Jumpstart Advance Care Planning with Alaska Native and American Indian peoples in Primary Care. Res Sq [Preprint]. 2025 Sep 19:rs.3.rs-7400899. doi: 10.21203/rs.3.rs-7400899/v1.

    PubMed 41001527

Questions about this trial

What is this clinical trial studying?

A study testing JUMPSTART-ANAI in people with Advance Care Planning, run by Southcentral Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shannon Medlock, MS ((907)729-6322, smedlock@scf.cc), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with an advance directive in the electronic health record (time frame: Baseline, 3 months, 6 months, 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06538493, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in